Fred van Leuven
Corporate Officer/Principal bei Katholieke Universiteit Leuven
Aktive Positionen von Fred van Leuven
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
Karriereverlauf von Fred van Leuven
Ehemalige bekannte Positionen von Fred van Leuven
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AC IMMUNE SA | Gründer | 13.02.2003 | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Gründer | 01.01.2002 | - |
Ausbildung von Fred van Leuven
| Ghent University | Graduate Degree |
Statistik
International
| Belgien | 4 |
| Schweiz | 2 |
Operativ
| Founder | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Börse
- Insiders
- Fred van Leuven
- Erfahrung
